Heska Corp - Strategic SWOT Analysis Review

Heska Corp - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Heska Corp (Heska), a subsidiary of Mars Inc is an animal healthcare company, engaged in the development, manufacturing, and commercialization of veterinary diagnostic and specialty products for canine and feline companion animal health. The company’s major products include digital imaging diagnostic instruments, point of care laboratory instruments and consumables, software and services, allergy testing and immunotherapy, local and cloud-based data services, digital cytology services and others. Heska other products also include single use offerings such as in-clinic diagnostic tests and heartworm preventive products. It also provides vaccines and other pharmaceuticals for cattle including porcine, avian, equine, feline and canine. The company offers its products to companion animal veterinarians. It has presence in the US, UK, Canada, Mexico, Germany, Switzerland, Australia, France, Spain, and others. Heska is headquartered in Loveland, Colorado, the US.

Heska Corp Key Recent Developments

May 05,2023: Heska Corporation Reports First Quarter 2023 Results
Apr 21,2023: Heska Announces Annual Meeting of Stockholders on May 3, 2023
Feb 28,2023: Heska Corporation Reports Fourth Quarter and Full Year 2022 Results
Feb 08,2023: Heska Fourth Quarter and Full Year 2022 Financial Results and Earnings Call Scheduled for February 28, 2023

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note:Some sections may be missing if data is unavailable for the company.